Myelodysplastic Syndrome Market Size in 7MM is expected to witness a major change in the study period 2019-2032 | Major Companies- Novartis, Sanofi, and Others

PRESS RELEASE
Published April 19, 2023

DelveInsight’s “Myelodysplastic Syndrome Market” report provides a thorough comprehension of the Myelodysplastic Syndrome historical and forecasted epidemiology and the Myelodysplastic Syndrome market trends in the 7MM [the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan]. The Myelodysplastic Syndrome market report also proffers an analysis of the current Myelodysplastic Syndrome treatment algorithm/practice, market drivers, market barriers, and unmet medical needs.

The Myelodysplastic Syndrome market is expected to show positive growth, mainly attributed to the increased diagnosed prevalence and also, the launch of upcoming devices during the forecast period. Moreover, advances in disease mechanisms have yielded new diagnostic and treatment approaches, opening avenues to better treatment interventions.

Key Takeaways from the Myelodysplastic Syndrome Market Research Report

  • Several key pharmaceutical companies, including Bristol-Myers Squibb, Astex Pharmaceutical, Taiho Oncology, Fibrogen, AbbVie, Gilead Sciences, Novartis, Syros Pharmaceuticals, Takeda, Pfizer, Geron Corporation, Karyopharm Therapeutics, Antengene Corporation, BerGenBio ASA, Jazz Pharmaceuticals, Aprea Therapeutics, Sanofi, Medac, and others, are developing novel products to improve the Myelodysplastic Syndrome treatment outlook.
  • Companies such as Bristol Myers Squibb, Aprea Therapeutics, Geron Corporation, and others are developing therapies targeting specific mutations like TP53, IDH2, RARA, etc. This will provide more precise treatment for Myelodysplastic Syndrome patients not responding or having poor outcomes toward the current standard of treatment.
  • Myelodysplastic Syndrome market to grow because of the increasing disease awareness programs, development of therapies for the second-line setting, robust pipeline activity, potential of upcoming therapies. However, the growth of the Myelodysplastic Syndrome market will be impeded by lack of MDS treatment pattern studies, underdiagnosis of disease, the high-cost burden for MDS treatment, and progression of patients toward AML.
  • Few late stage therapies with Breakthrough therapy designations for MDS include: Abbvie’s  Venclexta (Venetoclax), Gilead Sciences’ Magrolimab and Takeda’s Pevonedistat. Venclexta is already approved for chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL) and newly-diagnosed (AML), and we expect the company to get an edge while occupying more of the market share in blood cancer through MDS as well. Another rival geared up in the field is Gilead Sciences, investigating Magrolimab (anti-CD47 Monoclonal Antibody) in combination with azacitidine for treatment-naïve intermediate, high, and very high-risk MDS.
  • During ASH 2021, Takeda’s Pevonedistat plus azacitidine combination interim results did not appear to improve outcomes compared with azacitidine alone among patients with HR-MDS, CMML, or AML. Even after the dissapointing interim results, the company is looking forward to the full data set for further guidance.
  • Apart from these therapies receiving breakthrough designations, another leading candidate, Sabatolimab (MBG453), by Novartis is a humanized anti-TIM-3 IgG4 antibody that is in the late phase of development for the treatment of MDS, AML, and other malignancies.
  • Not just for the first-line segment, a handful of companies are also exploring their drug candidates for the second-line pool, such as Karyopharm Therapeutics/Antengene Corporation, Bristol Myers Squibb, and others.
  • In an era where we have a bunch of chimeric antigen receptor therapies (CAR-T cells) being tried in almost every hematological cancer, there is just one company that is focused on working for MDS, Celyad Oncology, who are evaluating the next-generation NKG2D-based CAR-T candidate for the treatment of R/R AML/MDS

Download sample of the Myelodysplastic Syndrome market research report @ Myelodysplastic Syndrome Market Size  

Myelodysplastic Syndrome Overview

Myelodysplastic Syndrome is a heterogeneous group of hematologic neoplasms classically described as a clonal disorder of hematopoietic stem cells leading to dysplasia and ineffective hematopoiesis in the bone marrow.

Myelodysplastic Syndrome Epidemiology Segmentation in the 7MM

  • Total Myelodysplastic Syndrome Incident Population
  • Age-specific Incident Population
  • Subtype-specific Incident Population
  • Risk-specific Incident Population
  • Mutation-specific Incident Population

For more information about the epidemiology segmentation of the Myelodysplastic Syndrome epidemiology report @ Myelodysplastic Syndrome Epidemiology Segmentation

Myelodysplastic Syndrome Treatment Market

The current Myelodysplastic Syndrome treatment landscape for patients comprises allo-HSCT, non-intensive therapies ranging from iron chelation and growth factors to lenalidomide and HMA. Allo-HSCT remains the only curative for this patient pool. Other approaches are non-curative, improving quality of life, and delaying disease progression.

Myelodysplastic Syndrome Therapies

Other than these current therapies, the Myelodysplastic Syndrome pipeline is robust and possesses multiple potential drugs in the late, mid, and early stages of developments, yet to be launched. The emerging pipeline of MDS possesses several potential products developed in different stages of clinical development. The expected launch of potential therapies, namely FibroGen (roxadustat), AbbVie (Venclexta ± azacitidine), Novartis (sabatolimab), Syros Pharmaceuticals (SY-1425 + azacitidine), Gilead Sciences (magrolimab ± azacitidine), Geron Corporation (imetelstat), Takeda (pevonedistat ± azacitidine), Pfizer (glasdegib + azacitidine), Aprea Therapeutics (eprenetapopt), Jazz Pharmaceuticals (CPX-351), Karyopharm Therapeutics (eltanexor), BerGenBio (bemcentinib), Bristol Myers Squibb (enasidenib), Sanofi (fludarabine + busulfan ± clofarabine and Medac (treosulfan ± fludarabine) may increase Myelodysplastic Syndrome market size in the coming years, assisted by an increase in the MDS patient pool.

Learn more about the Myelodysplastic Syndrome therapies in clinical trials @ Myelodysplastic Syndrome Ongoing Clinical Trials Analysis

Myelodysplastic Syndrome Market Analysis

Myelodysplastic Syndrome market to growing due to the current MDS treatment options that include curative, supportive, and symptomatic treatments, which are easily and widely available in the market, and their generics. Moreover, various studies have highlighted the role of multiple gene mutations like RUNX1, TP53, TET2, DNMT3A, ASXL1, and others in MDS. The emerging therapies such as Syros Pharma’s SY-1425 and BMS’ Enasidenib are being developed as targeted therapies for RARA positive and IDH-2 mutated patients, respectively. The companies are developing therapies with targetable mutations that will open a new window of opportunity for companies developing MDS therapies.

Myelodysplastic Syndrome Market Growth

However, the growth of the Myelodysplastic Syndrome market will be hampered by the lack of the latest evidence and analysis related to drug prescription pattern share for Myelodysplastic Syndrome patients in EU5 countries. Also, the disease affects old age people, and most of these patients are ineligible for HSCT, which is currently the only curative option. Some MDS patients undergoing treatment with HMA might fail the therapy, due to which they might not have many treatment options left. In addition to that, the upcoming therapies might face some competition from the approved and established therapies for MDS and the various upcoming therapies in the Myelodysplastic Syndrome pipeline. The high-cost burden for the overall Myelodysplastic Syndrome treatment might threaten the current MDS market.

Discover more information about the Myelodysplastic Syndrome market report offering @ Myelodysplastic Syndrome Treatment Market

Scope of the Myelodysplastic Syndrome Market Insight Report

  • Geography Covered: 7MM
  • Study Period: 20190-2032
  • Myelodysplastic Syndrome Markets Segmentation: By Geographies and By Myelodysplastic Syndrome Therapies (Historical and Forecasted, Current and Upcoming)
  • Dominant Myelodysplastic Syndrome companies in the market: Bristol-Myers Squibb, Astex Pharmaceutical, Taiho Oncology, Fibrogen, AbbVie, Gilead Sciences, Novartis, Syros Pharmaceuticals, Takeda, Pfizer, Geron Corporation, Karyopharm Therapeutics, Antengene Corporation, BerGenBio ASA, Jazz Pharmaceuticals, Aprea Therapeutics, Sanofi, Medac, and several others.
  • Myelodysplastic Syndrome Market Dynamics: Myelodysplastic Syndrome Market Drivers and Barriers

Request a Sample of the Myelodysplastic Syndrome Market Forecast Report @ Myelodysplastic Syndrome Market Drivers and Barriers

Table of content

  1. Key Insights
  2. Executive Summary of Myelodysplastic Syndrome
  3. Competitive Intelligence Analysis for Myelodysplastic Syndrome
  4. Myelodysplastic Syndrome: Market Overview at a Glance
  5. Myelodysplastic Syndrome: Disease Background and Overview
  6. Patient Journey
  7. Myelodysplastic Syndrome Epidemiology and Patient Population
  8. Treatment Algorithm, Current Treatment, and Medical Practices
  9. Myelodysplastic Syndrome Unmet Needs
  10. Key Endpoints of Myelodysplastic Syndrome Treatment
  11. Myelodysplastic Syndrome Marketed Products
  12. Myelodysplastic Syndrome Emerging Therapies
  13. Myelodysplastic Syndrome: Seven Major Market Analysis
  14. Attribute analysis
  15. 7MM: Market Outlook
  16. Access and Reimbursement Overview of Myelodysplastic Syndrome
  17. KOL Views
  18. Market Drivers
  19. Market Barriers
  20. Appendix
  21. DelveInsight Capabilities
  22. Disclaimer
  23. About DelveInsight

Speak to our Business Consultant @ Myelodysplastic Syndrome Emerging Therapies, Companies, and Future Perspectives

List of Top Selling Market Research Reports in 2023

Bag3-related Gene Therapies Market

Bag3-related Gene Therapies Market Insights, Epidemiology, and Market Forecast-2032″ report delivers an in-depth understanding of the Bag3-related Gene Therapies, forecasted epidemiology

Cannabis Use Disorder Market

DelveInsight’s Cannabis Use Disorder Market Insights, Epidemiology and Market Forecast – 2032 report provides the detailed overview of the disease and in depth understanding of historical.

Chronic Smell and Flavor Loss Market

DelveInsight’s Chronic smell and flavor loss Market Insights, Epidemiology, and Market Forecast-2032″ report delivers an in-depth understanding of the Chronic smell and flavor

Congenital ichthyosis Market

DelveInsight’s Congenital ichthyosis Market Insights, Epidemiology, and Market Forecast-2032″ report delivers an in-depth understanding of the Congenital ichthyosis epidemiology

Coronary Microvascular Dysfunction Market

DelveInsight’s Coronary Microvascular Dysfunction Market Insights, Epidemiology, & Market Forecast 2032 report delivers an in-depth understanding of the CMD epidemiology & CMD market trends

Immune Thrombocytopenia Market

DelveInsight’s Immune Thrombocytopenia Market Insights, Epidemiology and Market Forecast – 2032 report provides the detailed overview of the disease and in depth understanding of historical.

Renal Tubular Acidosis Market

DelveInsight’s Renal Tubular Acidosis Market Insights & Market Forecast-2032 report delivers an in-depth understanding of the Renal Tubular Acidosis, historical and forecasted epidemiology.

Secondary Progressive Multiple Sclerosis SPMS Market

Secondary Progressive Multiple Sclerosis Market Insights, and Market Forecast report delivers an in-depth understanding of the Secondary Progressive Multiple Sclerosis epidemiology

Canaloplasty Market

DelveInsight’s ‘Canaloplasty -Market Insights, Competitive Landscape and Market Forecast – 2027’ report delivers an in-depth understanding of Canaloplasty and the historical.

Familial Lipoprotein Lipase Deficiency Market

DelveInsight’s Familial Lipoprotein Lipase Deficiency Market Insights, Epidemiology and Market Forecast – 2032 report provides the detailed overview of the disease and in depth.

Osteochondrodysplasia Market

Osteochondrodysplasia Market report delivers an in-depth understanding of the Osteochondrodysplasia Market size, epidemiology as well as the pipeline therapies.

Ranibizumab Biosimilars Insight

DelveInsight’s, “Ranibizumab– Biosimilar Insight, 2022” report provides comprehensive insights about 20+ companies and 20+ marketed and pipeline drugs in Ranibizumab Biosimilars landscape.

Sick Sinus Syndrome Market

DelveInsight’s Sick Sinus Syndrome Market Insights, Epidemiology, and Market Forecast-2032″ report delivers an in-depth understanding of the Sick Sinus Syndrome forecasted epidemiology

Glioblastoma Multiforme Market

DelveInsight’ s Glioblastoma Multiforme (GBM) – Market Insights, Epidemiology and Market Forecast – 2030 report provides the detailed overview of the disease and in depth.

Clostridium Difficile Infections Market

Clostridium Difficile Infections Market report delivers an in-depth understanding of the historical and forecasted epidemiology as well as the market trends in the 7MM

Liver Fibrosis Market

DelveInsight’s Liver Fibrosis Market Insights, Epidemiology, and Market Forecast-2032″ report delivers an in-depth understanding of the Liver Fibrosis.

Hepatic Cirrhosis Market

DelveInsight’s Hepatic Cirrhosis Market Insights, Epidemiology, and Market Forecast report delivers an in-depth understanding of the Hepatic Cirrhosis, historical and forecasted epidemiology

Scoliosis Market

Scoliosis Market Insights, Epidemiology, Market Forecast report delivers an understanding of Scoliosis, historical and forecasted epidemiology as well as the Scoliosis market trends in 7MM

Smoking Cessation and Nicotine Addiction Market

Smoking Cessation and Nicotine Addiction Market Insights, Forecast report delivers an in-depth understanding of the Smoking Cessation and Nicotine Addiction forecasted market trends in 7MM

Spondylolisthesis Market

DelveInsight’s Spondylolisthesis Market Insights, Epidemiology, and Market Forecast-2032″ report delivers an in-depth understanding of the Spondylolisthesis, historical and forecasted epidemiology as well as the Spondylolisthesis market trends in 7MM.

Supraventricular Tachycardia Market

DelveInsight’s Supraventricular Tachycardia Market Insights, Epidemiology, and Market Forecast-2032″ report delivers an in-depth understanding of the Supraventricular Tachycardia, historical and forecasted epidemiology as well as the Supraventricular Tachycardia market trends in 7MM.

TCR Therapy Market

TCR Therapy Market Insights, Epidemiology, and Market Forecast-2032 report deliver an in-depth understanding of TCR Therapy forecasted epidemiology as well as the TCR Therapy market trends

Tendonitis Market

Tendonitis Market Research report delivers an in-depth understanding of the Tendonitis Market Size, Share, Epidemiology as well as the key Companies

UK Healthcare Outlook Report 2022

DelveInsight’s,“UK Healthcare Outlook Report, 2022,” provides comprehensive insights about the healthcare scenario, regulatory policies and reimbursement landscape in UK.

Adeno-Associated Virus Vectors in Gene Therapy Market

Adeno-Associated Virus Vectors in Gene Therapy Market Insights report delivers an understanding of Adeno-Associated Virus Vectors in Gene Therapy epidemiology.

Attention-deficit/hyperactivity disorder ADHD Market

Attention-deficit/hyperactivity disorder ADHD Market Insights, Forecast report delivers an in-depth understanding of the Attention-deficit/hyperactivity disorder ADHD forecasted epidemiology.

Paranasal Sinus Cancer Market

Paranasal Sinus Cancer Market Insights, Epidemiology, Market Forecast report delivers an in-depth understanding of the Paranasal Sinus Cancer epidemiology

Seasonal Allergic Rhinitis Market

DelveInsight’s Seasonal Allergic Rhinitis Market Insights, Epidemiology, and Market Forecast-2032″ report delivers an in-depth understanding of the Seasonal Allergic Rhinitis epidemiology

Lumbar Degenerative Disc Disease Market

DelveInsight’s Lumbar Degenerative Disc Disease (DDD) Market Insights, Epidemiology and Market Forecast – 2032 report provides the detailed overview of the disease.

Post operative pain management Market

DelveInsight’s Post operative pain management Market Insights, Epidemiology, and Market Forecast-2032″ report delivers an in-depth understanding of the Post operative pain management, historical and forecasted epidemiology as well as the Post operative pain management market trends in 7MM.

Rhinitis Market

DelveInsight’s Rhinitis Market Insights, Epidemiology, and Market Forecast-2032″ report delivers an in-depth understanding of the Rhinitis, historical and forecasted epidemiology.

Herpes Labialis Market

DelveInsight’s Herpes Labialis Market Insights, Epidemiology, and Market Forecast-2032″ report delivers an in-depth understanding of the Herpes Labialis forecasted epidemiology.

Tonic clonic Seizure Market

DelveInsight’s Tonic-clonic Seizure Market Insights, Epidemiology, and Market Forecast-2032″ report delivers an in-depth understanding of the Tonic-clonic Seizure forecasted epidemiology.

Sarcopenia Market

DelveInsight’s Sarcopenia Market Insights, Epidemiology, and Market Forecast-2032″ report delivers an in-depth understanding of the Sarcopenia, historical and forecasted epidemiology

Uveitis Market

DelveInsight’s Uveitis Market Insights, Epidemiology, and Market Forecast-2032″ report delivers an in-depth understanding of the Uveitis.

Obstructive Sleep Apnea Market

DelveInsight’s Obstructive Sleep Apnea (OSA) Market Insights, Epidemiology, and Market Forecast-2032″ report delivers an in-depth understanding of the Obstructive Sleep Apnea (OSA)..

Somatotropin Deficiency Market

DelveInsight’s Somatotropin Deficiency Market Insights, Epidemiology, & Market Forecast report delivers an in-depth understanding Somatotropin Deficiency, historical & forecast epidemiology.

Surgical Robotic System Market

Surgical Robotic System Market Research Report provides comprehensive insights into the Surgical Robotic System Market Size, Share, Key Companies, Competitive Analysis.

Tuberculosis Market

DelveInsight’s Tuberculosis Market Insights, Epidemiology, and Market Forecast-2032″ report delivers an in-depth understanding of the Tuberculosis, historical and forecasted epidemiology

Vitreoretinal Surgery Devices Market

DelveInsight’s ‘Vitreoretinal Surgery Devices Market Insights, Competitive Landscape and Market Forecast-2027’ report delivers an in-depth understanding of Vitreoretinal Surgery Devices.

Inflammatory Pain Market

Inflammatory Pain Market Insights, Epidemiology, and Market Forecast-2032 report deliver an understanding of the forecasted epidemiology, and the Inflammatory Pain market trends in 7MM.

Electrophysiology Devices Market

DelveInsight’s ‘Electrophysiology devices -Market Insights, Competitive Landscape and Market Forecast – 2027’ report delivers an in-depth understanding of Electrophysiology devices.

Vascular Grafts Devices Market

Vascular Grafts Devices Market Research Report provides comprehensive insights into the Vascular Grafts Devices Market Size, Share, Key Companies, Competitive Analysis.

Biopsy Devices Market

DelveInsight’s ‘Devices Biopsy Devices Market Insights, Competitive Landscape and Market Forecast-2027’ report delivers an in-depth understanding of Devices Biopsy Devices

Fertility Testing Devices Market

Fertility Testing Devices Market Insight, Competitive Landscape and Market Forecast, 2027’ report delivers an in-depth understanding of Fertility Testing Devices medical devices market.

Dyspepsia Market

DelveInsight’s Dyspepsia Market Insights, Epidemiology, and Market Forecast-2032″ report delivers an in-depth understanding of the Dyspepsia, historical and forecasted epidemiology

Cystic Fibrosis Market

DelveInsight’s Cystic fibrosis Market Insights, Epidemiology, and Market Forecast-2032″ report delivers an in-depth understanding of the Cystic fibrosis.

Prostate Cancer Market

DelveInsight’s Prostate Cancer Market Insights, Epidemiology and Market Forecast – 2032 report provides the detailed overview of the disease and in depth understanding of historical.

Sepsis Market

DelveInsight’s Sepsis Market Insights, Epidemiology, and Market Forecast-2032″ report delivers an in-depth understanding of the Sepsis, historical and forecasted epidemiology

Lactose Intolerance Market

DelveInsight’s Lactose Intolerance Market Insights, Epidemiology, and Market Forecast-2032″ report delivers an in-depth understanding of the Lactose Intolerance, historical and forecasted epidemiology as well as the Lactose Intolerance market trends in 7MM.

Diabetic Wounds Market

Diabetic Wounds Market Research Report provides comprehensive insights into the Diabetic Wounds Market Size, Share, Key Companies, Competitive Analysis as well as the Market Forecast.

Venous Thromboembolism Market

DelveInsight’s Venous Thromboembolism Market Insights, Epidemiology, and Market Forecast-2032″ report delivers an in-depth understanding of the Venous Thromboembolism, historical and forecasted epidemiology as well as the Venous Thromboembolism market trends in 7MM.

About Us

DelveInsight is a Business Consulting and Market research company, providing expert business solutions for the healthcare domain and offering quintessential advisory services in the areas of R&D, Strategy Formulation, Operations, Competitive Intelligence, Competitive Landscaping, and Mergers & Acquisitions.

Contact Us

Yash Bhardwaj

info@delveinsight.com

Newsmantraa